Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ibrutinib and Nivolumab in Pts w/ Relapsed or Refractory Classical Hodgkin’s Lymphoma

Protocol: OSU-16077

Full Title

A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin’s Lymphoma

Lymphoma Hodgkin’s Lymphoma